| LYNOZYFIC 200 mg concentrate for solution for infusion EU/1/25/1917/002 |
Linvoseltamab |
Regeneron Ireland Designated Activity Company |
— |
| LYNOZYFIC 5 mg concentrate for solution for infusion EU/1/25/1917/001 |
Linvoseltamab |
Regeneron Ireland Designated Activity Company |
— |
| Lynparza 100 mg Film-coated tablet EU/1/14/959/002-003 |
Olaparib |
AstraZeneca AB |
— |
| Lynparza 150 mg Film-coated tablet EU/1/14/959/004-005 |
Olaparib |
AstraZeneca AB |
— |
| Lyrica 100 mg hard capsules EU/1/04/279/014-016 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 150 mg hard capsules EU/1/04/279/017-019 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 150 mg orodispersible tablets EU/1/04/279/053-055 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 20 mg/ml oral solution EU/1/04/279/044 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 200 mg hard capsules EU/1/04/279/020-022 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 225 mg hard capsules EU/1/04/279/033-035 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 25 mg hard capsules EU/1/04/279/001-005 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 25 mg orodispersible tablets EU/1/04/279/047-049 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 300 mg hard capsules EU/1/04/279/023-025 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 50 mg hard capsules EU/1/04/279/006-010 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 75 mg hard capsules EU/1/04/279/011-013 |
Pregabalin |
Upjohn EESV |
— |
| Lyrica 75 mg orodispersible tablets EU/1/04/279/050-052 |
Pregabalin |
Upjohn EESV |
— |
| LysaKare 25 g/25 g Solution for infusion EU/1/19/1381/001 |
L-lysine hydrochloride, L-arginine hydrochloride |
Advanced Accelerator Applications |
— |
| Lysodren 500mg tablets EU/1/04/273/001 |
Mitotane |
Esteve Pharmaceuticals S.A. |
— |
| Lytenava 25 mg/mL solution for injection EU/1/24/1798/001 |
Bevacizumab |
Outlook Therapeutics NL B.V. |
— |
| Lytgobi 4 mg film-coated tablet EU/1/23/1741/001-003 |
Futibatinib |
Taiho Pharma Netherlands B.V. |
— |
| Lyumjev EU/1/20/1422/001-012 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Lyvdelzi 10 mg hard capsules EU/1/24/1898/001 |
Seladelpar lysine dihydrate |
Cymabay Ireland Limited |
— |
| M-M-RvaxPro powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live) EU/1/06/337/1-13 |
Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Measles virus live attenuated derived from the edmonston b strain |
Merck Sharp & Dohme BV, |
— |
| Maalox Plus Chewable Tablets 200 mg/200 mg/25 mg PA23180/008/002 |
ALUMINIUM OXIDE, HYDRATED PH. EUR, MAGNESIUM HYDROXIDE PH. EUR., Dimeticone ph. eur. (as simeticone ph. eur.) |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Maapliv solution for infusion EU/1/25/1955/001 |
Alanine, Arginine, Aspartic Acid, Cysteine hydrochloride monohydrate, Glutamic acid |
Recordati Rare Diseases |
— |
| MabThera 100 mg concentrate for solution for infusion EU/1/98/067/001 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 1400 mg concentrate for solution for infusion EU/1/98/067/003 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 1600 mg concentrate for solution for infusion EU/1/98/067/004 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 500 mg concentrate for solution for infusion EU/1/98/067/002 |
Rituximab |
Roche Registration GmbH |
— |
| Maci EU/1/13/847/001 |
Autologous chondrocytes |
Sanofi B.V. |
— |
| Macitentan Accord 10 mg film-coated tablets EU/1/25/1970/001-008 |
Macitentan |
Accord Healthcare S.L.U. |
— |
| Macitentan AccordPharma 10 mg film-coated tablets EU/1/25/1971/001-008 |
Macitentan |
Accord Healthcare S.L.U. |
— |
| Macitentan MSN 10 mg film-coated tablets PA23250/017/001 |
Macitentan |
MSN Labs Europe Limited |
Not marketed |
| Magnesium Verla 5 mmol granules for oral solution PA0074/062/001 |
Magnesium |
Rowa Pharmaceuticals Limited |
Marketed |
| Maintelyte solution for infusion PA2299/045/001 |
Sodium chloride, GLUCOSE MONOHYDRATE PH. EUR., Sodium acetate, trihydrate, POTASSIUM CHLORIDE PH. EUR., MAGNESIUM CHLORIDE HEXAHYDRATE PH. EUR. |
Baxter Holding B.V. |
Marketed |
| Marixino 10 mg film-coated tablets EU/1/13/820/001-013 |
Memantine hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Marixino 20 mg film-coated tablets EU/1/13/820/014-026 |
Memantine hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Matever 100 mg/ml concentrate for solution for infusion EU/1/11/711/030 |
Levetiracetam |
Pharmathen S.A. |
— |
| Matever 1000 mg film-coated tablets EU/1/11/711/023-029 |
Levetiracetam |
Pharmathen S.A. |
— |
| Matever 250 mg film-coated tablets EU/1/11/711/001-006 |
Levetiracetam |
Pharmathen S.A. |
— |
| Matever 500 mg film-coated tablets EU/1/11/711/007-014 |
Levetiracetam |
Pharmathen S.A. |
— |
| Matever 750 mg film-coated tablets EU/1/11/711/015-022 |
Levetiracetam |
Pharmathen S.A. |
— |
| MAVENCLAD 10 mg tablets EU/1/17/1212/001-006 |
Cladribine |
Merck Europe B.V. |
— |
| Maviret 100 mg/40 mg film-coated tablets EU/1/17/1213/001 |
Pibrentasvir, Glecaprevir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 50 mg/20 mg coated granules in sachet EU/1/17/1213/003 |
Glecaprevir, Pibrentasvir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Mayzent 0.25 mg film-coated tablets EU/1/19/1414/001-002 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 1 mg film-coated tablets EU/1/19/1414/007-008 |
SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 2 mg film-coated tablets EU/1/19/1414/003 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| mCOMBRIAX dispersion for injection in pre-filled syringe. Influenza and COVID-19, mRNA vaccine. EU/1/26/2028/001-002 |
mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein, mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein, mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein, mRNA-1283 |
Moderna Biotech Spain S.L. |
— |
| Mebeverine hydrochloride 135 mg Film-coated Tablets PA22871/006/001 |
Mebeverine hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |